Publications

5891 Results

Heterogeneity in CBFB/MYH11 fusion messages encoded by inv(16) and t(16;16) in acute myelogenous leukemia (AML)

Authors
J Downing;S Shurtleff;S Meyers;S Hiebert;S Raimondi;D Head;C Willman;S Wolman;A Carroll;F Behm;F Collins;P Liu
Journal / Conference
International Academy of Pathology Book of Abstracts :109A(#630)
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9007, SWOG-9031

Amplification of the E2F-1 transcription factor gene in the HEL erythroleukemia cell line

Authors
M Saito;K Helin;MB Valentine;BB Griffith;CL Willman;E Harlow;AT Look
Journal / Conference
Genomics 25:130-138
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9007, SWOG-9031

Heterogeneity in CBF'/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia

Authors
SA Shurtleff;S Meyers;SW Hiebert;SC Raimondi;D Head;CL Willman;SR Wolman;ML Slovak;AJ Carroll;F Behm;MG Hulshof;TA Motroni;T Okuda;P Liu;FS Collins;JR Downing
Journal / Conference
Blood 85(12):3695-3703
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9007, SWOG-9031

Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)

Authors
JD Licht;C Chomienne;A Goy;A Chen;AA Scott;DR Head;JL Michaux;Y Wu;A DeBlasio;WH Miller Jr;AD Zelenetz;CL Willman;Z Chen;S-J Chen;A Zelent;E Macintyre;A Veil;J Cortes;H Kantarjian;S Waxman
Journal / Conference
Blood 85(4):1083-1094
Year
1995

Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia.

Authors
B Mehrotra;TI George;K Kavanau;H Avet-Loiseau;D Moore II;Cl Willman;ML Slovak;S Atwater;DR Head;MG Pallavicini
Journal / Conference
Blood 86(3):1139-1147
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8750, SWOG-9007, SWOG-9031

Trisomy 11: an association with stem/progenitor cell immunophenotype.

Authors
ML Slovak;ST Traweek;CL Willman;DR Head;KJ Kopecky;RE Magenis;FR Appelbaum;SJ Forman
Journal / Conference
British Journal of Hematology 90:266-273
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8326/27, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120)

Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: A Southwest Oncology Group study.

Authors
J Rinehart;KA Margolin;P Triozzi;E Hersh;M Campion;D Resta;D Levitt
Journal / Conference
Clinical Cancer Research 1:1139-1144
Year
1995
Research Committee(s)
Developmental Biologics
Study Number(s)
SWOG-9026

Concurrent cisplatin (CDDP), prolonged oral etoposide (E) and vincristine (VCR) plus chest and brain irradiation (RT) induction therapy for limited-stage small cell lung carcinoma (SCLC): Preliminary report of a Southwest Oncology Group study (SWOG-9229)

Authors
CR Thomas Jr;DJ Rector;KJ Stelzer;RB Livingston
Journal / Conference
ASCO 14:363(#1111)
Year
1995
Research Committee(s)
Lung
Study Number(s)
SWOG-9229

The Intergroup Study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.

Authors
CG Moertel;TR Fleming;JS Macdonald;DG Haller;JA Laurie;CM Tangen;JS Ungerleider;WA Emerson;DC Tormey;JH Glick;MH Veeder;JA Mailliard
Journal / Conference
Journal of Clinical Oncology 13(12):2936-2943
Year
1995
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8591(NCI Intergroup #0035)

Phase III study of intraperitoneal (IP) cisplatin (CDDP)/intravenous (IV) cyclophosphamide (CPA) vs IV CDDP/IV CPA in patients (pts) with optimal disease stage III ovarian cancer: A SWOG-GOG-ECOG Intergroup Study (INT-0051)

Authors
DS Alberts;PY Liu;EV Hannigan;R O'Toole;SD Williams;J Young;EW Franklin;D Clarke-Pearson;VK Malviya;S DuBeshter;W Hoskins;M Adelson;RD Alvarez;S Vogel;J O'Sullivan;DJ Garcia;D Sparks;ML Rothenberg
Journal / Conference
ASCO 14:273(#760)
Year
1995
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8501 (INT-0051)